Getting High on Prescription Drug Safety in Kentucky- Research to Policy
|
|
- Jack Houston
- 5 years ago
- Views:
Transcription
1 Getting High on Prescription Drug Safety in Kentucky- Research to Policy Terry Bunn, PhD Svetla Slavova, PhD Kentucky Injury Prevention and Research Center University of Kentucky Kentucky Department for Public Health December 4, 2012
2 >50% of Kentucky adults surveyed reported being prescribed prescription pain relievers in last 5 years 1 in 3 Kentuckians (32%) surveyed reported they knew someone close who abused prescription pain relievers compared to 1 in 5 Ohioans. 40% of Kentuckians aged knew someone close who abused prescription pain relievers compared to 14% of those 65+. Foundation for a Healthy Kentucky, Misuse of prescription pain relievers in Kentucky, Kentucky Health Issues Poll, December 2011
3 Paulozzi et al. Vital signs: Overdoses of prescription opioid pain relievers- United States, MMWR, 60(43)
4 Paulozzi et al. Vital signs: Overdoses of prescription opioid pain relievers- United States, MMWR, 60(43)
5 IS THIS A WORK-RELATED ISSUE?
6 PRESCRIPTION DRUGS AND WORKER FATALITIES
7 Municipal Solid Waste Collector Dies after Falling from Solid Waste Vehicle Hopper Area Incident Number: 10KY006
8
9
10 11KY023
11
12 10KY073
13
14 PRESCRIPTION DRUGS AND WORKER INJURIES
15 2011 Workers Compensation Claims Ie has not reported a claim/injury to insd. Insd has recvd calls from providers alledging ee was hurt while working. Ee refused to take drug test. While using table saw, was holding piece of wood on left side, saw blade pulled piece into blade and pulled finger into path of blade. Drug screen is positive Vol fire fighter who was trying to restrain a combative patient (on drugs and violent)(assisting police to hold patient) and while police flipped the patient and tried to handcuff him the patients shoulder struck the claimant in the chest causing injury. Employee was opening a test tube for drug toxicology work. Test tube contained urine from positive drug tested subject. Conducting k-9 drug search, walked around car slipped on wet pavement falling on his wrist Ee is a deputy sheriff who injured rt shoulder while fighting with a suspect. Ee was serving drug search warrant in the process of wrestling with suspect to place him under arrest, ee injured rt shoulder. Claimant bent over to pick up shoe to check for specimen before administering drug test on patient & strained back.
16
17 Challenge Spring 2011 Only 32% of prescribers/dispensers of controlled substances enrolled in KASPER system Only 50% of pain management clinics owned by physicians
18 Project June 2011 Joint NCSL)/CDC meeting to address injury prevention at the state level KY Strategic injury prevention plan developed with a primary emphasis on the prevention of prescription drug abuse Key strategies introduction of legislation addressing low enrollment of controlled substance prescribers in the KASPER, and ownership of pain clinics by private individuals
19 KSPAN Prescription Drug Abuse Goals Workgroup 1. increased controlled substance prescriber KASPER enrollment 2. prescription drug takeback programs 3. pain clinic regulation 4. controlled substance provider training
20 Key Activities Informing: 1)Proposed legislation - Provision of data - Networking - Participation on policymaking committees 2)prescription drug takeback programs 3)healthcare provider-owned pain management clinics 4)formal training on prescription drug abuse
21 KSPAN Partners Kentucky Office of Drug Control Policy Operation UNITE KASPER staff Foundation for a Healthy Kentucky Kentucky Hospital Association Department for Behavioral Health, Developmental and Intellectual Disabilities.
22 Outcome Kentucky House Bill 1 passed/effective July 20, 2012 requires mandatory enrollment, and use of, KASPER by prescribers/dispensers of controlled substances all licensed practitioners shall maintain their KASPER registration ownership of pain management facilities by physicians with full active licenses. a 161% increase from 12/1/11 and 9/1/12 in number of eligible enrolled controlled substance prescribers/dispensers in KASPER.
23 PROFESSIONAL STANDARDS FOR PRESCRIBING/DISPENSING SCHEDULE II OR SCHEDULE III WITH HYDROCODONE Requirements Before Prescribing/Dispensing 1. Obtain complete medical history; document in record 2. Conduct physical examination; document in record 3. Query KASPER 4. Develop a written treatment plan set out objectives of treatment further diagnostic exams required 5. Discuss risks/benefits of controlled substance use risk of tolerance and dependence 6. Obtain written consent for treatment
24 Ongoing Evaluation Practitioner must review course of treatment at reasonable intervals Practitioner must provide patient with any new information about treatment Practitioner must query KASPER on patient at least once every 3 months Practitioner must review KASPER report before issuing any prescriptions or refills for these substances
25 "The full impact of House Bill 1 will not be realized for a while, however, the good news at this point is usage of our prescription monitoring program has increased from 3000 reports a day to 20,000. That increased usage is helping prescribers to make more informed prescribing decisions. "------Van Ingram, Executive Director of Kentucky Office of Drug Control Policy
26 Acknowledgements This work was supported in part by Cooperative agreement numbers 5U6OH from CDC-NIOSH and 5 U17/CE from the CDC. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC or NIOSH.
Data Integration and Analysis for Improved Drug Overdose Surveillance in Kentucky
Data Integration and Analysis for Improved Drug Overdose Surveillance in Kentucky Svetla Slavova, PhD Terry Bunn, PhD Bureau of Justice Assistance Research-Practitioner Partnership & Data-Driven Pilots
More informationDrug Overdose Morbidity and Mortality in Kentucky,
Drug Overdose Morbidity and Mortality in Kentucky, 2000-2010 An examination of statewide data, including the rising impact of prescription drug overdose on fatality rates, and the parallel rise in associated
More informationIdentification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities
Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities Svetla Slavova, PhD Sara LaMantia, MS Terry Bunn, PhD Tracey Corey, MD 2016 Safe States Annual Meeting April 13, 2016, Albuquerque,
More informationLouisiana. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Louisiana Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationOklahoma. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Oklahoma Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationRhode Island. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Rhode Island Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationArticle #2 Prescription Drug Overdose CDC: Centers for Disease Control and Prevention. Understanding the Epidemic
Article #2 Prescription Drug Overdose CDC: Centers for Disease Control and Prevention Understanding the Epidemic When the Prescription Becomes the Problem In a period of nine months, a tiny Kentucky county
More informationVirginia. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationCalifornia. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile California Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationMinnesota. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Minnesota Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationWest Virginia. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile West Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationNEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION
Chapter NEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION EFFECTIVE: Policy REVISED: 4/13/9 draft NALOXONE DISTRIBUTION POLICY I. PURPOSE: This New Mexico Department of Health (NMDOH)
More informationMandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable
Arizona Amends worker s compensation statute to require physicians to request PMP information within two (2) business days of writing or dispensing prescriptions for at least a 30 day supply of an opioid
More informationWHAT YOU NEED TO KNOW TO ABOUT AB 474
WHAT YOU NEED TO KNOW TO ABOUT AB 474 PRESENTED BY: NEVADA STATE BOARD OF OSTEOPATHIC MEDICINE 2275 Corporate Circle, Suite 210 Henderson, NV 89074 702-732-2147 Fax 702-732-2079 Web Site: www.bom.nv.gov
More informationTennessee. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Tennessee Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationKentucky s Strategic Action Plan. Katherine Marks, Ph.D. August 16, 2018
Kentucky s Strategic Action Plan Katherine Marks, Ph.D. August 16, 2018 OUTLINE The state & the need The organization of a response The action plan THE STATE AND THE NEED KENTUCKY 4.4 million people 35
More informationInterstate Variation in Prescribing of Opioid Pain Relievers and Benzodiazepines Karin A. Mack, PhD Associate Director for Science
Interstate Variation in Prescribing of Opioid Pain Relievers and Benzodiazepines Karin A. Mack, PhD Associate Director for Science National Center for Injury Prevention and Control Division of Analysis,
More informationState, District, or Territory Criteria for Mandatory Enrol ment or Query of PDMP
State, District, or Territory Alabama Arizona Arkansas Criteria for Mandatory Enrollment or Query of PDMP Before renewing an Alabama Controlled Substances Certificate, the applicant shall have a current
More informationSTATE PRESCRIPTION DRUG MONITORING PROGRAMS (PMPS): A NATIONAL PERSPECTIVE
STATE PRESCRIPTION DRUG MONITORING PROGRAMS (PMPS): A NATIONAL PERSPECTIVE PRESENTATION ON BEHALF OF THE NATIONAL ASSOCIATION OF STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) BY SHERRY L. GREEN OVERVIEW
More informationVermont. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Vermont Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of
More informationShawn A. Ryan, MD, MBA Assistant Professor, Dept. of Emergency Medicine, University of Cincinnati Chair of Quality & Patient Safety, Jewish
Shawn A. Ryan, MD, MBA Assistant Professor, Dept. of Emergency Medicine, University of Cincinnati Chair of Quality & Patient Safety, Jewish Hospital-Mercy Health Partners Addiction Specialist, BrightView
More informationUtah. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Utah Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view
More informationMandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable
Arizona Amends worker s compensation statute to require physicians to request PMP information within two (2) business days of writing or dispensing prescriptions for at least a 30 day supply of an opioid
More information2016 Drug Trends Series
Drug Trends Series Part 3: Assessing opioids and compounds Published August 2017 1 Drug Trends Series Opioids & Compounds First Script Introduction As with the first two editions in Coventry s Drug Trends
More informationCDC s Efforts to End the Opioid Epidemic
Amy Insert Peeples, CIO Name MPA Here Deputy Director, National Center for Injury Prevention and Control NCSL Opioid Policy Fellows Kick Off CDC s Efforts to End the Opioid Epidemic The Epidemic in America
More informationOpioid Prescription and Illicit Drug Overdoses: On the Rise
Opioid Prescription and Illicit Drug Overdoses: On the Rise Cindy Haynes, MSA-PA, CHES Chronic Pain Program Coordinator Northern Piedmont Community Care Duke Division of Community Health Objectives Define
More informationEMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC
EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC RAMI R KHOURY, MD, FACEP ASSISTANT MEDICAL DIRECTOR EMERGENCY CARE ALLEGIANCE HEALTH ADVERTISING AT ITS BEST! OVERDOSE
More informationSUBJECT: Opioid Overdose and Intranasal Naloxone Training for Law Enforcement: Train the Trainer Session: Queens County October 17, 2014
ANDREW M. CUOMO GOVERNOR STATE OF NEW YORK DIVISION OF CRIMINAL JUSTICE SERVICES Alfred E. Smith Office Building 80 South Swan Street Albany, New York 12210 http://criminaljustice.ny.gov MICHAEL C. GREEN
More informationAssociation of Manitoba Municipalities: 2018 Municipal Officials Seminar
Association of Manitoba Municipalities: 2018 Municipal Officials Seminar Cannabis Legalization: An Employer s Perspective Presented by: Kim Hunter and Todd Nadeau People First HR Services Full firm HR
More informationThe Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin.
The Wisconsin Prescription Drug Monitoring Program Wisconsin Nurses Association Jail Health Care Conference May 21, 2018 WI PDMP Timeline PDMP Overview January 2013 WI PDMP operational April 2017 WI epdmp
More informationUsing Prescription Drug Monitoring Program Data to Advance Prevention Planning
September 13, 2016 Using Prescription Drug Monitoring Program Data to Advance Prevention Planning Emerging Drug Issues and Trends Chelsey Goddard, Director, SAMHSA s Center for the Application of Prevention
More informationDrug Overdoses A Public Health Problem. Marianne Cloeren, MD, MPH, FACOEM, FACP 10/2/2013. Objectives
Drug Overdoses A Public Health Problem Marianne Cloeren, MD, MPH, FACOEM, FACP 10/2/2013 Objectives O Provide an overview of the trends in opioid prescriptions and impact O Consider implications for the
More informationORDINANCE NO AN ORDINANCE ESTABLISHING A POLICY FOR A DRUG-FREE WORKPLACE
ORDINANCE NO. 2003-03 AN ORDINANCE ESTABLISHING A POLICY FOR A DRUG-FREE WORKPLACE BE IT ORDAINED BY THE CITY COUNCIL OF CHEROKEE VILLAGE, ARKANSAS, THAT; SECTION 1. Purpose of Policy The City has a vital
More informationDrug Overdose Prevention Program (DOPP)
Drug Overdose Prevention Program (DOPP) GUIDELINES FOR IMPLEMENTATION [Type a quote from the documen T or the s ummary of an interesting p oint. You can position the text box anywhere in the document.
More informationPERMA 2016 ANNUAL CONFERENCE Drug and Alcohol Testing in the Workplace
PERMA 2016 ANNUAL CONFERENCE Drug and Alcohol Testing in the Workplace Presented By: Ronni M. Travers, SPHR President rtravers@publicsectorhr.org (518) 399-4512 How Big is the Problem? According to a Johns
More informationDATE ISSUED: 2/4/ of 6 LDU DHE(LOCAL)-X
Reasonable Suspicion Searches Alcohol or Controlled Substances Testing Types of Tests and Employees Subject to Testing Pre-Employment Testing Post-Accident Testing The District reserves the right to conduct
More informationPREVENTING PRESCRIPTION DRUG ABUSE AND OVERDOSE JUNE 23, 2016 SHERRY L. GREEN
PREVENTING PRESCRIPTION DRUG ABUSE AND OVERDOSE JUNE 23, 2016 SHERRY L. GREEN STATE LAW AND POLICY TRENDS STATE PRESCRIPTION DRUG MONITORING PROGRAMS (PMPS) Transformation into better health care tools
More informationThe Wisconsin Prescription Drug Monitoring Program
The Wisconsin Prescription Drug Monitoring Program DHS 2018 WI Opioid Forum April 12, 2018 Learning Objectives 1. How the WI epdmp supports healthcare professionals in making informed prescribing, dispensing
More informationMEDICATION MANAGEMENT AGREEMENT Pain Management Program Participation Agreement and Consent
MEDICATION MANAGEMENT AGREEMENT Pain Management Program Participation Agreement and Consent Pain may be effectively managed through the use of controlled substance medications (referred to below as opioids
More informationOpioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative
Opioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative John W. McIlveen, Ph.D., LMHC, State Opioid Treatment Authority, Oregon Health Authority, Addictions and Mental Health Division
More information2017 NASCSA Conference
2017 NASCSA Conference Drug Trends & Investigations Eric Griffin Director of Compliance & Enforcement Eric.griffin@pharmacy.ohio.gov 614-466-4143 www.pharmacy.ohio.gov Ohio Quick Facts 2006 Ohio established
More informationPrescription Drug Monitoring Programs and Other State-Level Strategies
Prescription Drug Monitoring Programs and Other State-Level Strategies Interventions to Reduce Opioid-Related Harms: Misuse, Abuse, Addiction, and Overdose Tamara M. Haegerich, PhD Acting Associate Director
More informationMandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable
Alaska Requires adoption of regulations that provide that a practitioner query the PDMP prior to dispensing, prescribing, or administering a Sch. II or III controlled substance; query is not required for
More informationCOMPLETE DRUG AND ALCOHOL POLICY & Testing Policy
COMPLETE DRUG AND ALCOHOL POLICY & Testing Policy... Rev 12/2012 1 I. STATEMENT OF POLICY Robért Resources LLC. ( Robért s ) and it s related companies is committed to providing safe, healthful, and efficient
More informationDrug and Alcohol Policy
CDL Program Drug and Alcohol Policy Effective as of [10/08/2018] Adopted by: Date Adopted: [10/08/2018] Last Revised: [10/08/2018] Table of Contents 1. Purpose of Policy... 3 2. Covered Employees... 3
More informationKentucky All Schedule Prescription Electronic Reporting (KASPER)
Kentucky All Schedule Prescription Electronic Reporting (KASPER) Phyllis Millspaugh Manager, Behavioral Health Prevention and Promotion Kentucky Cabinet for Health and Family Services Using PDMP Data to
More informationData-Driven Multidisciplinary Approaches to Reduce Prescription Drug Abuse in Kentucky
Data-Driven Multidisciplinary Approaches to Reduce Prescription Drug Abuse in Kentucky http://uknow.uky.edu/content/kentucky-awarded-grant-prescription-drugabuse-prevention-program Data-Driven Multidisciplinary
More informationGood Samaritan and Naloxone Bill Status Report Carryover 2015 and Special Sessions
Good Samaritan and Naloxone Bill Status Report Carryover 2015 and Special Sessions Research current through January 21, 2015 This project was supported by Grant No. G1399ONDCP03A, awarded by the Office
More informationEMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC
EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC RAMI R KHOURY, MD, FACEP ASSISTANT MEDICAL D IRECTOR EMERGENCY C A R E ALLEGIANCE HEALTH ADVERTISING AT ITS BEST! OVERDOSE
More informationA Bill Regular Session, 2015 SENATE BILL 717
Stricken language would be deleted from and underlined language would be added to present law. 0 State of Arkansas 0th General Assembly As Engrossed: S// H// A Bill Regular Session, SENATE BILL By: Senator
More informationPennsylvania Prescription Drug Monitoring Program Trends,
DEA Intelligence Report Brief DEA-PHL-DIR-006-17 Pennsylvania Prescription Drug Monitoring Program Trends, 2014-2015 December 2016 1 Executive Summary The abuse and diversion of pharmaceutical drugs, particularly
More informationNorth Carolina, like the rest of the nation, has been experiencing
INVITED COMMENTARY The North Carolina Controlled Substances Reporting System: A Valuable Tool for Combating Prescription Drug Misuse William D. Bronson Prescription drug misuse is a growing problem that
More informationS 0332 S T A T E O F R H O D E I S L A N D
LC00 01 -- S 0 S T A T E O F R H O D E I S L A N D IN GENERAL ASSEMBLY JANUARY SESSION, A.D. 01 A N A C T RELATING TO HEALTH AND SAFETY - COMPREHENSIVE DISCHARGE PLANNING Introduced By: Senators Miller,
More informationFIGHTING ADDICTION AND IMPROVING BEHAVIORAL HEALTH
FIGHTING ADDICTION AND IMPROVING BEHAVIORAL HEALTH The Public Health Crisis of This Generation & Delaware s Plan for the Future Lt. Governor Bethany Hall-Long, Ph.D, RNC, FAAN INTRODUCTION BEHAVIORAL HEALTH
More informationSeptember 1, The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201
September 1, 2017 The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201 Dear Secretary Price: The National Association of County
More informationAVEDA FREDRIC S INSTITUTE DRUG FREE SCHOOL POLICY
AVEDA FREDRIC S INSTITUTE DRUG FREE SCHOOL POLICY The Aveda Fredric s Institute believes that it is very important to provide a safe environment for all of its students and Team Members. Substance abuse,
More informationASTHO President s Challenge 15 x 15: Reduce Prescription Drug
ASTHO President s Challenge 15 x 15: Reduce Prescription Drug Misuse and Deaths 15% by 2015 Terry Cline, Ph.D. Commissioner of Health Oklahoma Secretary of Health and Human Services Prescription drugs
More informationBill 18 - The Testing of Bodily Fluids and Disclosure Act
Paramedic Association of Manitoba Submission to Standing Committee on Social and Economic Development Bill 18 - The Testing of Bodily Fluids and Disclosure Act April 28, 2008 By means of introduction,
More information2018 Annual Meeting & Educational Conference Opioids In Workers Compensation: Research From WCRI
2018 Annual Meeting & Educational Conference Opioids In Workers Compensation: Research From WCRI John W. Ruser, Ph.D. NCSI 2018 Annual Meeting June 12, 2018 AGENDA Introduce WCRI Opioid dispensing to injured
More informationASPMN Conference Baltimore, Maryland
ASPMN Conference Baltimore, Maryland Prescribing Controlled Substances Managing Risk and Optimizing Outcomes September 13, 2012 Tracey Fremd, NP Tracey Fremd Consulting, Inc. Most Common Uses for Controlled
More informationInjury Surveillance Program, Massachusetts Department of Public Health Fall 2017
Number of Deaths Injury Surveillance Program, Massachusetts Department of Public Health Fall 217 Suicide and self-inflicted injuries are a significant yet largely preventable public health problem. The
More informationAhsan U. Rashid, M.D., F.A.C.P.
Ahsan U. Rashid, M.D., F.A.C.P. OPIOID MAINTENANCE AND CONSENT Instructions: Review this document before signing. This document will help both the patient and caregivers in establishing a medical program
More informationPublic Health Impacts of 2016 West Virginia Legislation
Public Health Impacts of 2016 West Virginia Legislation Sherri A. Young, DO, FAAFP WVSOM Summer Seminar North Myrtle Beach, South Carolina June 15, 2016 1 Objectives Passage and implementation of Expedited
More informationCrowe Healthcare Webinar Series
Crowe Healthcare Webinar Series Healthcare Providers Ongoing Challenges With Controlled Substances Presented by: Scott Gerard, Healthcare Risk Consulting Partner Eric Jolly, Healthcare Risk Vice President
More informationPrescription Monitoring Programs: An Update on Interstate Data Sharing
Prescription Monitoring Programs: An Update on Interstate Data Sharing National Conference of State Legislatures July 28, 2010 David R. Hopkins Kentucky Cabinet for Health and Family Services Office of
More informationShining a Light on MEDs Understanding morphine equivalent dose
Shining a Light on MEDs Understanding morphine equivalent dose In the workers compensation industry, 60.2 percent of claimants utilize opioid analgesics for the treatment of pain caused by a workplace
More informationEvaluation of the N.C. Prescription
Evaluation of the N.C. Prescription Drug Monitoring Program 2013 National Meeting of the Safe States Alliance and SAVIR MarianaGarrettson Garrettson, MPH Chris Ringwalt, DrPH UNC Injury Prevention Research
More informationNew Mexico. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile New Mexico Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationSeeing through the Smoke: Preparing Your Workplace for Legalized Marijuana. October 23, 2018
Seeing through the Smoke: Preparing Your Workplace for Legalized Marijuana October 23, 2018 Let s Be Blunt... With the many new state laws being passed legalizing medical and recreational marijuana, employers
More informationDrug Overdose Deaths among Kentucky Residents, December, 2018
Injury Prevention and Research Center Drug Overdose Deaths among Residents, 1999-217 December, 218 Prepared by David Akers MA, MS Peter Rock, MPH Svetla Slavova, PhD Terry L. Bunn, PhD Released by Injury
More informationHigh-Decile Prescribers: All Gain, No Pain?
High-Decile Prescribers: All Gain, No Pain? Len Paulozzi, MD, MPH National Center for Injury Prevention and Control Centers for Disease Control and Prevention National Center for Injury Prevention and
More informationThe Legal Implications Of Prescription Medication Abuse In The Workers' Compensation Environment McAnany, Van Cleave & Phillips, P.A.
The Legal Implications Of Prescription Medication Abuse In The Workers' Compensation Environment 2013 McAnany, Van Cleave & Phillips, P.A. The Wicked Witch of the West Schedule II substances are those
More informationNew York. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile New York Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationPerformance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)
Performance of North Carolina's System for Monitoring Prescription Drug Abuse Session Law 2015-241, Section 12F.16.(q) Report to the Joint Legislative Oversight Committee on Health and Human Services and
More informationCoalition of Behavioral Health Agencies Conference January 24, 2013
Coalition of Behavioral Health Agencies Conference January 24, 2013 Adam Karpati, MD MPH Executive Deputy Commissioner for Mental Hygiene New York City Department of Health and Mental Hygiene Prioritizing
More informationFighting Today s Opioid Epidemic
Fighting Today s Opioid Epidemic Establish in 1966 as a Public Health Department Location: Rock Falls, IL/Whiteside County Population: Whiteside County 2015--57,079 Serving Rural IL: Primarily Whiteside,
More informationLegal Issues in Opioid Prescribing
Legal Issues in Opioid Prescribing Joanne L. Martin, J.D. Legal Counsel Mayo Clinic Rochester, Mn 2015 MFMER slide-1 Conflict of Interest I have no relevant financial relationships to disclose I will not
More informationDrug Diversion Recognition and Prevention in a Hospital Setting. Natalie Tuttle PharmD, BCPS, DPLA University of Toledo Medical Center
Drug Diversion Recognition and Prevention in a Hospital Setting Natalie Tuttle PharmD, BCPS, DPLA University of Toledo Medical Center 1 Disclosure I have no actual or potential conflict of interest in
More informationProposed Revision to Med (i)
Proposed Revision to Med 501.02 (i) I. Purpose This rule has been adopted to enable the Board to best protect public health and safety while providing a framework for licensees to effectively treat and
More informationUnderstanding the Opioid Crisis: What s at the Heart of the Matter?
National Center for Injury Prevention and Control Understanding the Opioid Crisis: What s at the Heart of the Matter? Sara Patterson Associate Director for Policy National Center for Injury Prevention
More informationFederal Partner Roundtable: CDC Updates
Federal Partner Roundtable: CDC Updates Amy Valderrama, PhD, RN, ACNP-BC Nurse Epidemiologist Healthcare Preparedness and Response Team (HPRT) Division of State and Local Readiness (DSLR) March 8, 2017
More informationThe Anatomy of a Complex Workers Compensation Claim
The Anatomy of a Complex Workers Compensation Claim Presented by: Stacy Corluccio, TAC RMS Claims Manager and Helana Barmore, TAC WC Claims Manager: York Risk Services Group Talking Points Medical benefits
More informationThe Changing Landscape of Opioids & Workers Compensation. Presented by: David Campbell, MA, CRC State of Michigan Workers Compensation Agency
The Changing Landscape of Opioids & Workers Compensation Presented by: David Campbell, MA, CRC State of Michigan Workers Compensation Agency 1 The Changing Landscape of Opioids & Workers Compensation is
More informationTHE GENERAL ASSEMBLY OF PENNSYLVANIA HOUSE BILL
PRINTER'S NO. 10 THE GENERAL ASSEMBLY OF PENNSYLVANIA HOUSE BILL No. 00 Session of 01 INTRODUCED BY FRANKEL, DiGIROLAMO, CRUZ, BAKER, FABRIZIO, DEAN, BROWNLEE, READSHAW, KILLION, BISHOP, McGEEHAN, THOMAS,
More informationErgonomics and the Farm. Keri A. Gill-Smith, Physical Therapist
Ergonomics and the Farm Keri A. Gill-Smith, Physical Therapist Farm Injury Rates Farming involves hard physical work Every day about 167 agricultural workers suffer a lost-work-time injury From 2008-2010,
More informationPrescription Drug Overdose
2017 Prescription Drug Overdose Stark County Pilot Project Report 1 Table of Contents Acknowledgements 3 Executive Summary 4 Project Flow Chart 5 Project Implementation 6 Project Results 8 Lessons Learned
More informationDONALD W. WYATT DETENTION FACILITY WYATT TRAINING CENTER
PHYSICAL FITNESS TEST MEDICAL CERTIFICATE Name Date Dear Physician: The above-named individual has submitted an application to become a Correctional Officer at the Central Falls Detention Facility Corporation
More informationNC General Statutes - Chapter 90 Article 5E 1
Article 5E. North Carolina Controlled Substances Reporting System Act. 90-113.70. Short title. This Article shall be known and may be cited as the "North Carolina Controlled Substances Reporting System
More informationS 2356 SUBSTITUTE A AS AMENDED ======== LC004564/SUB A/3 ======== S T A T E O F R H O D E I S L A N D
0 -- S SUBSTITUTE A AS AMENDED LC00/SUB A/ S T A T E O F R H O D E I S L A N D IN GENERAL ASSEMBLY JANUARY SESSION, A.D. 0 A N A C T RELATING TO HEALTH AND SAFETY -- INSURANCE--MENTAL ILLNESS AND SUBSTANCE
More informationPotential Solutions to Epidemic Substance Abuse in US and Europe
Potential Solutions to Epidemic Substance Abuse in US and Europe Richard C. Dart, MD, PhD Director, Rocky Mountain Poison and Drug Center, Denver Health 1 Professor, University of Colorado School of Medicine
More informationPrescription Drug Impact in the Workplace
Prescription Drug Impact in the Workplace Iowa Drugged Driving Summit September 27, 2016 Tess Benham, Sr. Program Manager, National Safety Council 1 Drug Overdoses now cause more deaths than car crashes.
More informationMARYLAND BOARD OF PHARMACY
MARYLAND BOARD OF PHARMACY CONTRACEPTION REGULATIONSAnd Other Legislative Initiatives THE ROAD FROM CONCEPTUALIZATION TO IMPLEMENTATION Deena Speights-Napata Executive Director Maryland Board of Pharmacy
More informationWhat is drug diversion?
Learning Objectives Identify the impact of drug diversion on patients and healthcare organizations Explain the common points of risks and methods of drug diversion in healthcare s controlled substance
More informationMichael M. Miller, MD, FASAM, FAPA
Michael M. Miller, MD, FASAM, FAPA mmiller@rogershospital.org Medical Director, Herrington Recovery Center (HRC) Rogers Memorial Hospital Oconomowoc, Wisconsin Vice Speaker Wisconsin Medical Society Clinical
More informationOPIOID EMERGENCY RESPONSE REGULATION
Province of Alberta PUBLIC HEALTH ACT OPIOID EMERGENCY RESPONSE REGULATION Alberta Regulation 99/2017 With amendments up to and including Alberta Regulation 87/2018 Office Consolidation Published by Alberta
More informationIllinois Prescription Monitoring Program. Sarah Pointer, Pharm D. Clinical Director of the Illinois Prescription Monitoring Program
Illinois Prescription Monitoring Program Sarah Pointer, Pharm D. Clinical Director of the Illinois Prescription Monitoring Program Agenda Provide an overview of the Illinois Prescription Monitoring Program
More informationWhite Paper on. Prescription Drug Abuse
White Paper on Prescription Drug Abuse October 22, 2014 Table of Contents: I. Introduction II. Scope of the Problem III. Most Common Drugs Involved in Overdoses IV. Efforts in Tennessee V. Prescription
More informationAcupuncture. Opioid Prescribing: Pitfalls for Occupational Medicine Physicians
Opioid Prescribing: Pitfalls for Occupational Medicine Physicians Presented by Scott Levy M.D. M.P.H. FACOEM Assistant Regional Medical Director, Occupational Health Services The Permanente Medical Group
More informationPharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation.
Pharmacy Law 2016 Ronda H. Lacey, J.D., M.S. Pharm Disclosure Statement I have no conflicts of interest to disclose related to this presentation. Objectives At the conclusion of this continuing education
More information